EUVIMEDEUVIMED entdecken
Validierungsstudie

Development and validation of an UPLC-ESI–MS/MS method for simultaneous quantification of antineoplastic agents and their metabolites in human plasma after unintentional exposure

Eline Verscheure iD, Ilana Struys, Matteo Creta, Katrien Poels, Jeroen Vanoirbeek, Liesbeth Lenaerts, Frédéric Amant, Manosij Ghosh, Lode Godderis

Archives of Toxicology · 2025

DOI: 10.1007/s00204-024-03900-5 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Archives of Toxicology, 2025. Verfasst von Eline Verscheure und 8 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Herestraat 49, 3000, Leuven, Belgium. Hauptthemen laut MEDLINE: Tandem Mass Spectrometry, Spectrometry, Mass, Electrospray Ionization, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Fonds Wetenschappelijk Onderzoek.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclophosphamide, daunorubicin, epirubicin, doxorubicin and paclitaxel are commonly used drugs in cancer treatment. However, there are no methods available enabling simultaneous measurement of these compounds and their metabolites in human plasma. Our aim was to develop and validate a sensitive method for simultaneous quantification of multiple antineoplastic drugs and their major metabolites in plasma. Solid phase extraction with Oasis PRiME HLB cartridges was used for sample clean-up. The samples were separated on an Acquity UPLC BEH C18 column, ionised by electrospray ionisation and detected with tandem mass spectrometry. The method was validated based on selectivity, extraction efficiency, matrix effect, process efficiency, linearity, sensitivity, precision and accuracy. The established LLOQs were 0.05 ng/mL (cyclophosphamide), 30 ng/mL (4-oxo-cyclophosphamide), 0.3 ng/mL (doxorubicin, daunorubicinol), 0.7 ng/mL (epirubicin, epirubicinol, doxorubicinol), 1 ng/mL (daunorubicin and paclitaxel) and 5 ng/mL (6-alpha-hydroxypaclitaxel). Afterwards, the method was tested in a real-life, unintentional exposure setting. Twenty-two plasma samples of matched maternal and cord blood pairs from pregnant cancer patients treated with chemotherapy were analysed. This resulted in two positive samples, with cyclophosphamide concentrations up to 0.37 ng/mL. The validated method is now ready to be applied in the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tandem Mass SpectrometrySpectrometry, Mass, Electrospray IonizationAntineoplastic AgentsHumansReproducibility of ResultsChromatography, High Pressure LiquidCyclophosphamideFemaleSolid Phase ExtractionLimit of DetectionDoxorubicin

Stichwörter der Autor:innen

Antineoplastic drugBiomonitoringLiquid chromatography-mass spectrometryMethod validation

Substanzen

Antineoplastic AgentsCyclophosphamideDoxorubicin

Autor:innen und Institutionen

  • Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Herestraat 49, 3000, Leuven, Belgium.
  • Department of Oncology, KU Leuven, Herestraat 49, 3000, Louvain, Belgium.
  • Unit Environmental Hygiene and Human Biological Monitoring, Department of Health Protection, National Health Laboratory (LNS), Rue Louis Rech 1, 3555, Dudelange, Luxembourg.
  • Gynecologic Oncology, Antoni Van Leeuwenhoek-Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Department of Obstetrics and Gynaecology, University Hospitals Leuven, Herestraat 149, Louvain, Belgium.
  • Centre for Environment and Health, Department of Public Health and Primary Care, KU Leuven, Herestraat 49, 3000, Leuven, Belgium. lode.godderis@kuleuven.be.

ORCID-Profile: Eline Verscheure

Förderung

  • Fonds Wetenschappelijk Onderzoek

Zitieren

APA

Verscheure, E., Struys, I., Creta, M., Poels, K., Vanoirbeek, J., Lenaerts, L., Amant, F., Ghosh, M., & Godderis, L. (2025). Development and validation of an UPLC-ESI–MS/MS method for simultaneous quantification of antineoplastic agents and their metabolites in human plasma after unintentional exposure. Archives of Toxicology. https://doi.org/10.1007/s00204-024-03900-5

Vancouver

Verscheure E, Struys I, Creta M, Poels K, Vanoirbeek J, Lenaerts L, et al. Development and validation of an UPLC-ESI–MS/MS method for simultaneous quantification of antineoplastic agents and their metabolites in human plasma after unintentional exposure. Archives of Toxicology. 2025. doi:10.1007/s00204-024-03900-5

BibTeX
@article{Verscheure2025,
  author = {Verscheure, Eline and Struys, Ilana and Creta, Matteo and Poels, Katrien and Vanoirbeek, Jeroen and Lenaerts, Liesbeth and Amant, Frédéric and Ghosh, Manosij and Godderis, Lode},
  title = {Development and validation of an UPLC-ESI–MS/MS method for simultaneous quantification of antineoplastic agents and their metabolites in human plasma after unintentional exposure},
  journal = {Archives of Toxicology},
  year = {2025},
  doi = {10.1007/s00204-024-03900-5}
}
Kostenlos starten →